BioSpace News Archive

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that data from a post-hoc analysis of the 22-week Phase 2 clinical study for its investigative drug candidate ralinepag, a next-generation, oral, selective and potent prostacyclin receptor agonist in development for the treatment of pulmonary arterial hypertension (PAH), will be presented at the American Thoracic Society (ATS) International Conference on May 23.

EMBOTRAP II Revascularization Device Captures and Removes Life-threatening Blood Clots, Rapidly Restores Blood Flow

New Survey Shows Nearly Two out of Three Women Believe Their Hands Make Them Look Older than Their Age

Steve Hoerter, Chief Commercial Officer at Agios Pharmaceuticals, Inc., Elected to Board of Directors

The new office expansion will enable Nautilus Medical to accommodate rapid growth and leverage the area’s diverse high-technology talent pool while strengthening existing partnerships with Google, Samsung and Breast We Can.

The product is effective for a wide range of treatments, including all types of motion sickness induced by travelling and morning sickness from pregnancy.

Company Celebrates 15 Years as One of America’s Largest Corporations

Upon FDA Approval, Aries Pharmaceuticals, Inc. to Lead U.S. Commercial Efforts.

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food & Drug

Altogen Labs announced addition of five new in-house validated xenograft models (4T1, BxPC-3, Calu-6, MDA-MB-468, and PANC-1).